
(AGENPARL) – SILVER SPRING mer 19 aprile 2023 •Indicated in adults and children with hereditary Factor X deficiency for:
?Routine prophylaxis to reduce the frequency of bleeding episodes
?On-demand treatment and control of bleeding episodes
?Perioperative management of bleeding in patients with mild and moderate hereditary Factor X deficiency
Fonte/Source: http://www.fda.gov/vaccines-blood-biologics/approved-blood-products/coagadex